Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Family Violence

Symnons E, Smit D, Muir K, Smith C

(2019), In: Textbook of Adult Emergency Medicine, 5th edition. Eds: Cameron C, Little M, Mitra B, Deasy C. Elsevier, Chapter 21.3

Contrast enhanced oesophageal avoidance for stereotactic body radiotherapy: Barium vs. Gastrografin

Woodford K, Panettieri V, Ruben JD, Davis S, Sim E, Tran Le T, Senthi S

(2019), Tech Innov Patient Support Radiat Oncol, 12, 16-22

DOI: 10.1016/j.tipsro.2019.10.004

Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

Palma DA, Olson R, Harrow S, Correa RJM, Schneiders F, Haasbeek CJA, Rodrigues GB, Lock M, Yaremko BP, Bauman GS, Ahmad B, Schellenberg D, Liu M, Gaede S, Laba J, Mulroy L, Senthi S, Louie AV, Swaminath A, Chalmers A, Warner A, Slotman BJ, de Gruijl TD, Allan A, Senan S

(2019), BMC Cancer, 19(1), 816

DOI: 10.1186/s12885-019-5977-6

Identifying optimal clinical scenarios for synchrotron microbeam radiation therapy: A treatment planning study

Smyth LML, Day LR, Woodford K, Rogers PAW, Crosbie JC, Senthi S

(2019), PHYS MEDICA, 60, 111-9

DOI: 10.1016/j.ejmp.2019.03.019

Long-term treatment outcomes of patients with primary optic nerve sheath meningioma treated with stereotactic radiotherapy

Ratnayake G, Oh T, Mehta R, Hardy T, Woodford K, Haward R, Ruben JD, Dally MJ

(2019), J Clin Neurosci, 68, 162-7

DOI: 10.1016/j.jocn.2019.07.005

Body size and dietary risk factors for aggressive prostate cancer: a case-control study

Pal M, Hodge AM, Papa N, MacInnis RJ, Bassett JK, Bolton D, Davis ID, Millar J, English DR, Hopper JL, Severi G, Southey MC, Milne RL, Giles GG

(2019), CANCER CAUSE CONTROL, 30(12), 1301-12

DOI: 10.1007/s10552-019-01234-7

Contemporary practice patterns of stereotactic radiosurgery for brain metastasis: A review of published Australian literature

Ong WL, Wada M, Ruben J, Foroudi F, Millar J

(2019), J MED IMAG RADIAT ON, 63(5), 711-20

DOI: 10.1111/1754-9485.12942

Forecasting annual incidence and mortality rate for prostate cancer in Australia until 2022 using autoregressive integrated moving average (ARIMA) models

Earnest A, Evans SM, Sampurno F, Millar J

(2019), BMJ Open, 9(8), e031331

DOI: 10.1136/bmjopen-2019-031331

Development of a muticentre automated model to reduce planning variability in radiotherapy of prostate cancer

Panettieri V, Ball D, Chapman A, Cristofaro N, Gawthrop J, Griffin P, Herath S, Howly S, Jukes L, Kron T, Markham C, Marr L, Moloney P, Nelli F, Ramachandran P, Smith A, Hornby CJ

(2019), Phys Imaging Radiat Oncol, 11, 39-40

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, Mulroy L, Lock M, Rodrigues GB, Yaremko BP, Schellenberg D, Ahmad B, Griffioen G, Senthi S, Swaminath A, Kopek N, Liu M, Moore K, Currie S, Bauman GS, Warner A, Senan S

(2019), Lancet, 393(10185), 2051-8

DOI: 10.1016/S0140-6736(18)32487-5

Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings

Beckmann K, O'Callaghan M, Vincent A, Cohen P, Borg M, Roder D, Evans S, Millar J, Moretti K

(2019), Asian J Urol, 6(4), 321-9

DOI: 10.1016/j.ajur.2019.03.001

Development of Technologic Solutions to Address Complex Local Requirements of an International Prostate Cancer Clinical Quality Registry

Sampurno F, Kannan A, Lucas M, Liman J, Connor SE, Pearman E, Millar JL, Moore CM, Villanti P, James E, Huland H, Litwin MS, Evans SM

(2019), JCO Clin Can Inform, 3, 1-11

DOI: 10.1200/CCI.18.00114

Improved survival for patients with prostate cancer receiving high-dose-rate brachytherapy boost to EBRT compared with EBRT alone

Kent AR, Matheson B, Millar JL

(2019), Brachytherapy, 18(3), 313-21

DOI: 10.1016/j.brachy.2019.01.013

A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03)

Wirth A, Prince HM, Roos D, Gibson J, O'Brien P, Zannino D, Khodr B, Stone JM, Davis S, Hertzberg M

(2019), INT J RADIAT ONCOL, 103(5), 1158-66

DOI: 10.1016/j.ijrobp.2018.12.006

The Use of Optimal Treatment for DLBCL Is Improving in All Age Groups and Is a Key Factor in Overall Survival, but Non-Clinical Factors Influence Treatment

Wong Doo N, White VM, Martin K, Bassett JK, Prince HM, Harrison SJ, Jefford M, Winship I, Millar JL, Milne RL, Seymour JF, Giles GG

(2019), Cancers, 11(7), 928

DOI: 10.3390/cancers11070928

Patterns of end-of-life hospital care for patients with non-Hodgkin lymphoma: exploring the landscape

Philip J, Collins A, Ritchie D, Le B, Millar J, McLachlan SA, Krishnasamy M, Hudson P, Sundararajan V

(2019), LEUKEMIA LYMPHOMA, 60(8), 1908-16

DOI: 10.1080/10428194.2018.1564047

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial

Ball D, Mai GT, Vinod S, Babington S, Ruben J, Kron T, Chesson B, Herschtal A, Vanevski M, Rezo A, Elder C, Skala M, Wirth A, Wheeler G, Lim A, Shaw M, Schofield P, Irving L, Solomon B; TROG 09.02 CHISEL investigators

(2019), Lancet Oncol, 20(4), 494-503

DOI: 10.1016/S1470-2045(18)30896-9

Interest in switching to on-demand HIV pre-exposure prophylaxis (PrEP) among Australian users of daily PrEP: An online survey.

Cornelisse VJ, Lal L, Price B, Ryan KE, Bell C, Owen L, Wright EJ

(2019), OPEN FORUM INFECT DI, 6(7), ofz287

DOI: 10.1093/ofid/ofz287

Gonorrhoea gone wild: rising incidence of gonorrhoea and associated risk factors among gay and bisexual men attending Australian sexual health clinics

Callander D, Guy R, Fairley CK, McManus H, Prestage G, Chow EPF, Chen M, Connor CCO, Grulich AE, Bourne C, Hellard M, Stoové M, Donovan B; ACCESS Collaboration

(2019), Sex Health, 16(5), 457-63

DOI: 10.1071/SH18097

Sexually transmissible infections among transgender men and women attending Australian sexual health clinics

Callander D, Cook T, Read P, Hellard ME, Fairley CK, Kaldor JM, Vlahakis E, Pollack A, Bourne C, Russell DB, Guy RJ, Donovan B

(2019), MED J AUSTRALIA, 211(9), 406-11

DOI: 10.5694/mja2.50322

292 293 294 295 296